Richard Whitley

Richard J.
Whitley is the founder of Immvira Bioscience, Inc., founded in 2015.
Dr. Whitley is the founder of Treovir Inc, founded in 2019.
Dr. Whitley is also the founder of Alabama Drug Discovery Alliance.
Current positions include Director at Primus Pharmaceuticals, Inc., Director at FermaVir Pharmaceuticals LLC since 2005, Co-Director-Pediatric Infectious Diseases at Washington University School of Medicine, Independent Director at Dogwood Therapeutics, Inc. since 2020, Member of the Association of American Physicians, Member of the American Society of Clinical Investigation, Professor at The University of Alabama at Birmingham, and Member-Supervisory Board at Leyden Laboratories BV.
Former positions include Chairman-Scientific Councilors at Centers for Disease Control & Prevention from 2000 to 2012, Chairman-HIV Vaccine Data Safety at National Institute of Allergy & Infectious Diseases, Independent Director at Gilead Sciences, Inc. from 2008 to 2021, Director at Gilead Connecticut, Inc., Independent Director at Virios Therapeutics, Inc., President of Infectious Diseases Society of America, and President of The International Society for Antiviral Research.
Education includes undergraduate and doctorate degrees from Duke University and a doctorate degree from George Washington University.